240 related articles for article (PubMed ID: 21894767)
1. [Positive effect of cytoflavin on metabolic status changes in patients with burn disorder].
Polutova NV; Ostrovskiĭ NV; Romantsov MG; Chesnokova NP
Eksp Klin Farmakol; 2011; 74(7):33-7. PubMed ID: 21894767
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of cytoflavin in the treatment of burns patients with toxic and post-hypoxic encephalopathy].
Pochepen' ON
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):23-9. PubMed ID: 21183910
[TBL] [Abstract][Full Text] [Related]
3. [Antioxidant therapy in discirculatory encephalopathy].
Antipenko EA; Gustov AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):53-5. PubMed ID: 21465819
[No Abstract] [Full Text] [Related]
4. [The results of using cytoflavin in conservative treatment of patients with obliterating atherosclerosis of the lower extremity vessels].
Bogomolov MS; Sedov VM; Edovina LN; Luk'ianov IuV; Slobodianiuk VV
Vestn Khir Im I I Grek; 2011; 170(1):43-6. PubMed ID: 21506354
[TBL] [Abstract][Full Text] [Related]
5. [Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial].
Rumyantsevа SA; Kovalenko AL; Silinа EV; Stupin VA; Kabaeva EN; Chichanovskaya LV; Nazarov MV; Tsukurova LA; Burenichev DV; Golikov KV; Salnikov MV; Belova LA; Mashin VV; Mazina NK; Zhilina EA; Kolotik-Kameneva OY; Sherman MA
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):45-52. PubMed ID: 26356615
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological correction of free radical disturbances and endotoxicosis in patients with diffuse peritonitis at the postoperative period].
Bagnenko SF; Mirzabaev AT; Batotsyrenov BV; Gorbachev NB; Miroshnichenko VN; Batotsyrenova KhV; Velikiĭ KF
Vestn Khir Im I I Grek; 2011; 170(5):14-6, 18. PubMed ID: 22238957
[TBL] [Abstract][Full Text] [Related]
7. [The influence of cytoflavin and cardioxipin on the indices of lipid peroxidation and antioxidant protection in the blood of rat with dyslipidemia].
Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
Eksp Klin Farmakol; 2014; 77(6):27-9. PubMed ID: 25102732
[TBL] [Abstract][Full Text] [Related]
8. [Antioxidant activity of cytoflavin in experimental diffuse purulent peritonitis].
Kosinets VA
Eksp Klin Farmakol; 2010 Jan; 73(1):30-2. PubMed ID: 20184286
[TBL] [Abstract][Full Text] [Related]
9. [Modern methods of energy homeostasis correction in elderly patients].
Rumiantseva SA; Silina EV; Tsukurova LA; Stupin VA; Chichanovskaia LV; Nazarov MV; Kovalenko AL; Kabaeva EN
Adv Gerontol; 2014; 27(4):746-52. PubMed ID: 25946854
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection].
Isakov VA; Kovalenko AL; Turkin VV; Makarov VI
Antibiot Khimioter; 2010; 55(1-2):36-41. PubMed ID: 20583556
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome].
Asadullaev MM; Saidvaliev FS; Shermukhamedova FK; Rizvonov ZhK; Vakhabova NM
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10):24-7. PubMed ID: 23250593
[TBL] [Abstract][Full Text] [Related]
12. [Antioxidant and membranoprotector treatment of chronic pyelonephritis].
Gordiushina IV; Savchenko RP; Sukhanov DS; Petrov AIu; Romantsov MG
Eksp Klin Farmakol; 2011; 74(4):27-30. PubMed ID: 21678656
[TBL] [Abstract][Full Text] [Related]
13. [Efficiency of intensive care with cytoflavin in patients of advanced age in combined traumatic brain injury].
Lebedeva EA; Belousova ME; Kurtasov AA; Nemkova ZA; Kaminskiĭ MIu; Popov RV; Trofimovich SL
Adv Gerontol; 2014; 27(3):578-83. PubMed ID: 25827011
[TBL] [Abstract][Full Text] [Related]
14. [Dynamics of the symptoms of chronic ischemia during the treatment with cytoflavin].
Madzhidova EN; Usmanova DD; Baĭtursunova ZhM
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):57-62. PubMed ID: 23235414
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of cytoflavin in patients with hypertonic encephalopathy and constitutional venous insufficiency].
Belova LA; Mashin VV; Kolotik-Kameneva OIu; Belova NV; Byrina AV; Evstigneeva AIu; Abramova VV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):21-6. PubMed ID: 23096033
[TBL] [Abstract][Full Text] [Related]
16. [The use of cytoflavin for the treatment of chronic brucellosis].
Shul'diakov AA; Liapina EP; Soboleva LA; Reshetnikov AA; Zubareva EV; Trubetskov AD; Anashchenko AV; Evdokimov AV
Klin Med (Mosk); 2011; 89(2):56-8. PubMed ID: 21574446
[TBL] [Abstract][Full Text] [Related]
17. [Experimental study on cytoflavin pharmacological correction of cyclophosphamide-induced toxic affections of the liver and kidneys].
Kashuro VA; Glushkov SI; Minaeva LV; Novikova TM
Antibiot Khimioter; 2010; 55(9-10):29-32. PubMed ID: 21400751
[TBL] [Abstract][Full Text] [Related]
18. [Neuroprotective effect of cytoflavin in closed craniocerebral trauma].
Bul'on VV; Zarubina IV; Kovalenko AL; Alekseeva LE; Sapronov NS
Eksp Klin Farmakol; 2003; 66(6):56-8. PubMed ID: 14743715
[TBL] [Abstract][Full Text] [Related]
19. [Antioxidant protection as a component of anesthetic management cancer patients].
Tumanian SV; Ivanova LG
Khirurgiia (Mosk); 2011; (6):66-9. PubMed ID: 21716223
[No Abstract] [Full Text] [Related]
20. [Comparative experimental study of antioxidant efficiency in treatment of acute pancreatitis].
Kliuĭko DA; Korik VE; Zhidkov SA
Eksp Klin Farmakol; 2011; 74(9):11-5. PubMed ID: 22164440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
